Authors:
Alscher, DM
Biegger, D
Mettang, T
Dunst, R
Wolken, D
Kuhlmann, U
Fritz, P
Citation: Dm. Alscher et al., Peritoneal metallothionein content in patients with end-stage renal disease on or not on peritoneal dialysis, PERIT DIA I, 21(1), 2001, pp. 92-94
Authors:
Pauli-Magnus, C
Murdter, T
Godel, A
Mettang, T
Eichelbaum, M
Klotz, U
Fromm, MF
Citation: C. Pauli-magnus et al., P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin, N-S ARCH PH, 363(3), 2001, pp. 337-343
Authors:
Pauli-Magnus, C
Mikus, G
Alscher, DM
Kirschner, T
Nagel, W
Gugeler, N
Risler, T
Berger, ED
Kuhlmann, U
Mettang, T
Citation: C. Pauli-magnus et al., Naltrexone does not relieve uremic pruritus: Results of a randomized, double-blind, placebo-controlled crossover study, J AM S NEPH, 11(3), 2000, pp. 514-519
Authors:
Mettang, T
Schwab, M
Pauli-Magnus, C
Alscher, DM
Kuhlmann, U
Citation: T. Mettang et al., Pruritus and anemia in a patient on peritoneal dialysis - Pitfalls in diagnosis for common symptoms, PERIT DIA I, 20(6), 2000, pp. 785-787
Citation: T. Mettang et C. Pauli-magnus, The pathophysiological puzzle of uremic pruritus - Insights and speculations from therapeutic and epidemiological studies, PERIT DIA I, 20(5), 2000, pp. 493-494
Authors:
Mettang, T
Pauli-Magnus, C
Alscher, DM
Kirchgessner, J
Wodarz, R
Rettenmeier, AW
Kuhlmann, U
Citation: T. Mettang et al., Influence of plasticizer-free CAPD bags and tubings on serum, urine, and dialysate levels of phthalic acid esters in CAPD patients, PERIT DIA I, 20(1), 2000, pp. 80-84
Authors:
Alscher, DM
Pauli-Magnus, C
Kuhlmann, U
Mettang, T
Citation: Dm. Alscher et al., Stimulated IFN gamma and IL-10 secretion of blood mononuclear cells in patients on renal replacement therapies show different secretion patterns, ARTIF ORGAN, 24(10), 2000, pp. 767-772
Authors:
Alscher, DM
Pauli-Magnus, C
Kirchgessner, J
Kuhlmann, U
Mettang, T
Citation: Dm. Alscher et al., A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: Effect on peripheral leukocyte function, NEPHRON, 86(1), 2000, pp. 62-69
Authors:
Pauli-Magnus, C
von Richter, O
Burk, O
Ziegler, A
Mettang, T
Eichelbaum, M
Fromm, MF
Citation: C. Pauli-magnus et al., Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein, J PHARM EXP, 293(2), 2000, pp. 376-382
Citation: C. Pauli-magnus et al., Acute renal failure in a patient with lupus-associated membranous nephropathy and severe nephrotic syndrome, DEUT MED WO, 124(25-26), 1999, pp. 788-792
Authors:
Pauli-Magnus, C
Hofmann, U
Mikus, G
Kuhlmann, U
Mettang, T
Citation: C. Pauli-magnus et al., Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis, NEPH DIAL T, 14(4), 1999, pp. 903-909
Authors:
Thomas, S
Fischer, FP
Mettang, T
Pauli-Magnus, C
Weber, J
Kuhlmann, U
Citation: S. Thomas et al., Effects of L-carnitine on leukocyte function and viability in hemodialysispatients: A double-blind randomized trial, AM J KIDNEY, 34(4), 1999, pp. 678-687
Authors:
Alscher, DM
Pfinder-Nohe, E
Rumpf, D
Pauli-Magnus, C
Knabbe, C
Kuhlmann, U
Mettang, T
Citation: Dm. Alscher et al., Moulds in containers with biological wastes as a possible source of peritonitis in two patients on peritoneal dialysis, PERIT DIA I, 18(6), 1998, pp. 643-646